These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18814369)

  • 41. [Four years without resistance--newer standard in HIV therapy].
    Dtsch Med Wochenschr; 2003 May; 128(19):1075-6. PubMed ID: 12774798
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug-resistance patterns in women discovered. Resistance testing necessary, expert says.
    AIDS Alert; 2005 Jan; 20(1):7-8. PubMed ID: 15717355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection.
    Smith D; Moini N; Pesano R; Cachay E; Aiem H; Lie Y; Richman D; Little S
    Clin Infect Dis; 2007 Feb; 44(3):456-8. PubMed ID: 17205459
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Selection and use of tests for detecting HIV resistance].
    Eiros JM; Hernández B; Labayru C; de Lejarazu RO
    Rev Esp Quimioter; 2001 Sep; 14(3):242-53. PubMed ID: 11753445
    [No Abstract]   [Full Text] [Related]  

  • 45. HIV drug resistance and you. Using resistance testing in clinical practice. U.S. guidelines, cost, limitations--and usefulness.
    Zawitz C
    Posit Aware; 2006; Spec No():10-2. PubMed ID: 16596728
    [No Abstract]   [Full Text] [Related]  

  • 46. Viro diversity (or, keeping up with HIV's evolutionary caprice).
    Mascolini M
    IAPAC Mon; 2001 Jul; 7(7):198-207. PubMed ID: 11785465
    [No Abstract]   [Full Text] [Related]  

  • 47. [GESIDA Consensus document on the use of resistance studies in clinical practice].
    Gatell JM; Blanco JL; Alcamí J; Antela A; Arrizabalaga J; Casado JL; Clotet B; Delgado R; Erice A; Guerra L; Guerrero A; Iribarren JA; Leal M; López JC; Menéndez-Arias L; Miró JM; Moreno S; Pérez JL; Pumarola T; Rubio R; Ruiz L; Santamaría JM; Soriano V; Telenti A; Viciana P
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):53-60. PubMed ID: 11428062
    [No Abstract]   [Full Text] [Related]  

  • 48. Guideline watch. HIV treatment guidelines updated.
    Zuger A
    AIDS Clin Care; 2006 Jun; 18(6):57. PubMed ID: 16791954
    [No Abstract]   [Full Text] [Related]  

  • 49. [HIV susceptibility determination: a qualified position against regarding a complex technology].
    Telenti A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):45-6. PubMed ID: 11428060
    [No Abstract]   [Full Text] [Related]  

  • 50. Resistance patterns analyzed in regional study of HIV patterns. Genotype test is routine for ART-naïve patients.
    AIDS Alert; 2007 May; 22(5):56. PubMed ID: 17577958
    [No Abstract]   [Full Text] [Related]  

  • 51. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 52. Drugs for HIV infection.
    Treat Guidel Med Lett; 2011 Jun; 9(106):29-40. PubMed ID: 21617596
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiretroviral resistance in the developing world.
    Pillay D
    J HIV Ther; 2007 Dec; 12(4):95-6. PubMed ID: 18578091
    [No Abstract]   [Full Text] [Related]  

  • 54. Epidemiology of antiretroviral resistance and impact on treatment outcomes.
    Cane P
    J HIV Ther; 2007 Dec; 12(4):82-4. PubMed ID: 18391892
    [No Abstract]   [Full Text] [Related]  

  • 55. [Primary resistance to antiretroviral agents].
    Soriano V; María Miró J; Guerrero A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):22-5. PubMed ID: 11428054
    [No Abstract]   [Full Text] [Related]  

  • 56. The K65R mutation: selection, frequency, and possible consequences.
    Moyle GJ
    AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical data marshalled to treat HIV.
    Clarke T
    Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390
    [No Abstract]   [Full Text] [Related]  

  • 58. HIV drug resistance tests: an update on methods for calculating phenotypic fold change from a viral genotype.
    Bellosillo NA; Bacheler L; Villacian J
    Clin Infect Dis; 2009 Mar; 48(5):687; author reply 687. PubMed ID: 19191661
    [No Abstract]   [Full Text] [Related]  

  • 59. New developments in HIV drug resistance.
    Cane PA
    J Antimicrob Chemother; 2009 Sep; 64 Suppl 1():i37-40. PubMed ID: 19675018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV drug resistance: overview of clinical data.
    Miller V
    J HIV Ther; 2001 Aug; 6(3):68-71. PubMed ID: 11555740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.